The makers of the frontrunner COVID-19 vaccine, AstraZeneca and Oxford University, were quick to downplay the illness that caused their clinical trials in five countries to come to a screeching halt earlier in September. However, the condition at the heart of the move, transverse myelitis, is actually a fairly common vaccine injury. The vaccine is being … Continue reading Myelitis observed in two COVID-19 vaccine trial participants is a common vaccine injury
Second AstraZeneca trial participant develops rare neurological condition following COVID-19 vaccination
It has come to our attention that a second participant in AstraZeneca’s Wuhan coronavirus (COVID-19) vaccine trials has come down with a serious neurological condition that the company claims is not at all related to the volunteer getting vaccinated. Just like the first participant, who we reported developed severe spinal inflammation, this second one also manifested the exact same disease, which … Continue reading Second AstraZeneca trial participant develops rare neurological condition following COVID-19 vaccination
“Serious adverse event” in AstraZeneca’s COVID-19 vaccine trial revealed as spinal inflammation disorder caused by toxic adjuvants
It has finally been revealed that the participant in AstraZeneca’s Wuhan coronavirus (COVID-19) vaccine trial who suffered a “serious adverse event,” causing a global shutdown of the company’s entire phase-three trial, developed a spinal inflammatory disorder known as transverse myelitis. Company CEO Pascal Soriot told JP Morgan and other investors over a conference call that the woman … Continue reading “Serious adverse event” in AstraZeneca’s COVID-19 vaccine trial revealed as spinal inflammation disorder caused by toxic adjuvants
Dr. Eddy Bettermann MD 